Performant Healthcare, Inc.
Performant Healthcare, Inc. (PHLT) Financial Performance & Income Statement Overview
Review Performant Healthcare, Inc. (PHLT) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Performant Healthcare, Inc. (PHLT) Income Statement & Financial Overview
View the income breakdown for Performant Healthcare, Inc. PHLT across both annual and quarterly reports.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $33.27M | $34.77M | $31.52M | $29.36M |
Cost of Revenue | $33.12M | $35.45M | $33.67M | $0.00 |
Gross Profit | $149999.00 | -$689000.00 | -$2.15M | $29.36M |
Gross Profit Ratio | $0.005 | -$0.02 | -$0.07 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $25.36M | $26.71M | $25.97M | $24.53M |
Operating Expenses | $33.12M | $35.45M | $33.67M | $32.10M |
Total Costs & Expenses | $33.12M | $35.45M | $33.67M | $32.10M |
Interest Income | $98000.00 | $99000.00 | $93000.00 | $61000.00 |
Interest Expense | $289000.00 | $306000.00 | $313000.00 | $300000.00 |
Depreciation & Amortization | $1.60M | $1.38M | $2.02M | $2.04M |
EBITDA | $1.85M | $785000.00 | -$41000.00 | -$645000.00 |
EBITDA Ratio | $0.06 | $0.02 | -$0.001 | -$0.02 |
Operating Income | $150000.00 | -$689000.00 | -$2.15M | -$2.74M |
Operating Income Ratio | $0.005 | -$0.02 | -$0.07 | -$0.09 |
Other Income/Expenses (Net) | -$191000.00 | -$207000.00 | -$220000.00 | -$239000.00 |
Income Before Tax | -$41000.00 | -$896000.00 | -$2.37M | -$2.98M |
Income Before Tax Ratio | -$0.001 | -$0.03 | -$0.08 | -$0.10 |
Income Tax Expense | $40000.00 | -$398000.00 | $15000.00 | $16000.00 |
Net Income | -$81000.00 | -$498000.00 | -$2.38M | -$3.00M |
Net Income Ratio | -$0.002 | -$0.01 | -$0.08 | -$0.10 |
EPS | -$0.001 | -$0.006 | -$0.03 | -$0.04 |
Diluted EPS | -$0.001 | -$0.006 | -$0.03 | -$0.04 |
Weighted Avg Shares Outstanding | $78.31M | $77.75M | $77.75M | $76.97M |
Weighted Avg Shares Outstanding (Diluted) | $78.31M | $77.75M | $77.75M | $76.97M |
Financial performance has remained strong, with revenue growing from $29.36M in Q2 2024 to $33.27M in Q1 2025. Gross profit continued to perform well, with margins at 1% in the latest quarter. Operating income reached $150000.00 in Q1 2025, holding a steady 1% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.85M. Net income rose to -$81000.00, keeping EPS at -$0.001. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan